October 2021: 5 Notable Drug Approvals
Review the October 2021 notable drug approvals.
Dry Eye
Tyrvaya Nasal Spray Now Available for Dry Eye Disease
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
MPR Weekly Dose Podcast Episode 97
This week: The FDA authorize boosters for Moderna and Janssen and okay ‘mixing and matching’ of vaccines for the booster dose. The first interchangeable biosimilar to Humira is approved. Also there’s approvals in dry eye disease, pain management and opioid overdoses.
Tyrvaya Nasal Spray Approved for Dry Eye Disease
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
Systane Hydration Multi-Dose Preservative-Free Formulation Now Available
The over-the-counter product may be used as a protectant against further eye irritation and to relieve dryness of the eye.
Varenicline Nasal Spray Under Review for Dry Eye Disease
The investigational nasal spray contains varenicline, a highly selective nicotinic acetylcholine agonist.
New Lubricant Eye Drops Help With Eye Dryness Related to Screen Use
Refresh Digital is designed to protect tears from evaporating due to incomplete blinking during digital device use.
Eysuvis Now Available For Dry Eye Disease
Eysuvis (loteprednol etabonate ophthalmic suspension) is now available for the short-term treatment of the signs and symptoms of dry eye disease.
Dry Eye Treatments
Over-the-counter (OTC) and prescription agents for the management of dry eye.
MPR Weekly Dose Podcast Episode 56
This week we cover a study that identified factors associated with strong antibody responses to COVID; How convalescent plasmas benefits may be limited; A nasal spray to treat diabetic gastroparesis; Recommendations for colorectal cancer screening; And a new treatment approved for dry eye disease. And of course, movie trivia!
